COVID-19

Consumer Discretionary
COVID-19
COVID-19 Variant
Defensive Stocks
Discretionary
Dividend Stocks
Dividend Yields
Dividends
Fibonacci Retracement
Fundamental Analysis
Fundamentals
Healthcare Management
Healthcare Solutions
Medical
Specialty Retailers
Technical Analysis
Vaccines
Valuations
Value Investing
Value Stocks

CVS has dropped about -7% in the last month. Where is its value price?

Looking for value in the stock market is something that I have found can be done in any market condition, but it is something that tends to get dismissed by most pundits simply because it isn’t very sexy. Names like Tesla, Netflix, and Amazon practically never pass the value list because the massive amount of […]

Read More
Coal
COVID-19
COVID-19 Variant
Dividend Stocks
Dividend Yields
Dividends
Fibonacci Retracement
Free Cash Flow
Fundamental Analysis
Petroleum
Rail
Railroad Stocks
Rising Interest Rates
Supply-Demand
Technical Analysis
Transportation
US Economy
Valuations
Value Investing
Value Stocks

CSX is up 20% in the last two months – is it worth its high price?

For a lot of different reasons, 2021 has been an interesting year for just about all of us. The pandemic has not abated this year as some experts predicted, and certainly as all of us hoped; the rise of the new COVID variants has kept pressures from the ongoing health crisis at the forefront of […]

Read More
Covid Shutdowns
COVID-19
COVID-19 Variant
Economic Collapse
Economic Trends
Economy

New COVID variant adds uncertainty for a Fed in the process of slowing support

The emergence of a new COVID variant spooked markets on Friday, forcing some Fed watchers to question if the Federal Reserve will change course on its plans to slow its monetary support to the U.S. economy. “Policy normalization already looked like it was going to be gradual but the developments that we see, the growth […]

Read More
COVID-19
Google
Vaccine Policy
Vaccines

Google staff protests over compulsory jabs show cracks in Joe Biden’s vaccine policy

Google Google’s chief executive Sundar Pichai is used to handling protests. The $2 trillion (£1.5 trillion) search engine giant has over the years faced staff revolts over the company’s work for the US military, sexual misconduct allegations against executives, and the firing of AI researchers who had highlighted bias in its technology. But Pichai may […]

Read More
COVID-19
Great Resignation
Unemployment

The Great Resignation: How Maslow’s ‘hierarchy of needs’ could be the key to stopping employees from quitting

Before the pandemic, effective leaders benefited from a deep understanding of human psychology, including what motivates people and makes them feel fulfilled. Today, they require it. Abstract psychological concepts like intrinsic motivation and a sense of belonging are the main indicators of strong work performance and company loyalty, David Rock, cofounder and CEO of the […]

Read More
COVID-19
Internet
Stimulus Checks

This little-known stimulus benefit helps pay for your internet and a new laptop

This little-known stimulus benefit helps pay for your internet and a new laptop Months after its launch and with millions of Americans now enrolled, a pandemic aid program still has money available to provide struggling households with monthly discounts on internet service and one-time savings on new computers. As part of a COVID stimulus package […]

Read More
COVID-19
Crude Oil
Eagle Ford Shale
Energy Crisis
Energy Production
Energy Sector
Energy Stocks
Fuel Distribution
Gasoline Prices
Inflation
Oil
Oil and Gas Pipelines
Oil Price
Oil Production
Oil Stocks
Oil Storage Facilities
Oil Supply
Permian Basin
Rising Interest Rates
Shale Oil
Technical Analysis
US Economy
Value Investing
Value Stocks
West Texas

Is HFC worth its bargain status?

The impact of the global pandemic sometimes seems to have no end in sight – even though economic activity has been picking up enough this year to start raising a lot of questions about inflationary pressures, their impact on interest rates, and more. One of the sectors that has rallied strongly since November of last […]

Read More
COVID-19
COVID-19 Pill
MRNA Vaccines
Novel Vaccines
Vaccines

Pfizer’s Covid Pill Is Shaking Up the Global Recovery Trade

(Bloomberg) — Shares tied to reopening trades from casinos to airlines surged in Asia on Monday after Pfizer Inc. said that its Covid-19 pill could reduce hospitalizations and deaths in high-risk patients by 89%. A Bloomberg gauge of Macau casino shares jumped 7.2%, the biggest move in over two months, while an index of Asia-Pacific […]

Read More
COVID-19
Stimulus Checks

Major COVID stimulus payments in line for 2022 extension — don’t miss your free cash

Major COVID stimulus payments in line for 2022 extension — don’t miss your free cash Congressional support is strong among Democrats to extend a popular stimulus payments program through next year despite a tug of war over Biden’s budget bill. House Speaker Nancy Pelosi will likely push ahead this week to finalize a draft of […]

Read More
Biopharmaceuticals
Biotech
Coronavirus
COVID-19
Dividend Stocks
Dividend Yields
Dividends
Fibonacci Retracement
Fundamental Analysis
Pharmaceuticals
Technical Analysis
Vaccines
Value Investing
Value Stocks

Is GILD’s pullback an opportunity to buy the stock at a nice price?

No matter how tired we get of hearing about COVID-19, there is no denying that ever since the virus found its way to American shores, a lot of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world worked nonstop […]

Read More
COVID-19
MRNA Vaccines
Novel Vaccines
Vaccines

Moderna’s Sales Miss Forecasts by 20%. Pfizer Is Taking the U.S. Vaccine Market.

Vials of the Moderna Covid-19 vaccine. Guillaume Souvant/AFP via Getty Images Moderna shares plunged 12.3% in premarket trading on Thursday after sales of the company’s Covid-19 vaccine fell short of Wall Street analysts’ estimates by more than a billion dollars. The company reported total revenue of $5 billion for the third quarter of the year, […]

Read More
Biopharmaceuticals
Biotech
Coronavirus
COVID-19
Dividend Stocks
Dividend Yields
Dividends
Fibonacci Retracement
Fundamental Analysis
Medical
Pharmaceuticals
Technical Analysis
Value Investing
Value Stocks

BMY is recovering from a big bearish drop – you should pay attention

Over the course of my investing career, I have learned to rely on a lot of fundamental data to paint a picture about the underlying strength of any stock I might consider using for a value-based investment. While some fundamental investors prefer to work with easy-to-reference, quick-glance data like earnings per share and price-to-earnings ratios, […]

Read More
COVID-19
Economy
Stimulus Checks
US Economy

With no fourth stimulus check, these COVID programs still offer billions in aid

With no fourth stimulus check, these COVID programs still offer billions in aid Federal policymakers, focused on negotiating President Joe Biden’s budget, show no signs of providing more broad stimulus payments. But many Americans who lost income in the pandemic are still looking for help, battered by rising prices for much of what they buy. […]

Read More
Consumer Discretionary
Consumer Retail
Coronavirus
COVID-19
Dividend Stocks
Dividend Yields
Dividends
Fibonacci Retracement
Fundamental Analysis
Healthcare Solutions
HeathCare
Medical
Pharmaceuticals
Technical Analysis
Value Investing
Value Stocks

WBA’s consolidation range and fundamental strength make it a nice value

For most of the past two years, stocks in the Health Care sector have drawn a lot of attention from investors and analysts. That includes stocks in the Pharmacy/Drugstore industry; these were names, like Walgreens Boots Alliance (WBA) and CVS Corporation (CVS) that worked actively in the early stages of the crisis as a critical […]

Read More
Business Services
Coronavirus
COVID-19
Digital Imaging
Digital Media
Digital Transformation
Dividend Yields
Dividends
Fibonacci Retracement
Fundamental Analysis
Information Technology
Paper
Remote Meetings
Technical Analysis
US Economy
Value Investing
Value Stocks
Work Management
Working From Home

XRX is down more than 14% in the last week – but the pundits might be wrong

One of the big challenges for average investors is sifting through the mountains of information that comes from the market on a daily basis. I think that may be the biggest reason that so many investors have learned over the course of decades of market activity to rely on analyst estimates for a company’s future […]

Read More
X